跳至主要内容
临床试验/CTRI/2018/03/012359
CTRI/2018/03/012359已完成2 期

Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy volunteers – a randomized placebo controlled trial

Natural Remedies Private Limited1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年2月4日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Joint pain reported on visual analogue scale

研究概览

简要总结

Objective: Curcuma longahas been widely used in Ayurveda for its medicinal properties and Turmacin wasdeveloped from C. longa as a standardized extract containingturmerosaccharides.In this clinical trial, the effect of Turmacin onknee joint discomfort in healthy adults subjected to strenuous physicalactivity was evaluated.

Design: Double-blind, triple-arm,parallel-group, randomized placebo-controlled trial.

Setting: Healthy participants from an urbantertiary care teaching hospital

Intervention: Healthy participants were randomizedin 1:1:1 ratio to receive either Turmacin 0.5g/1g or placebo once daily for 84days. The participants were subjected to 10-minute strenuous exercise.

Outcome measures: Time to initial pain, final painscore on a visual analogue scale, range of movement (ROM) of knee and the forceof contractions of muscles around the knee joint.

Results: A total of n=90 participants wererecruited. The meanfinal pain scores were significantly lower in the Turmacin 1g and Turmacin 0.5gwhen compared with the placebo from day-7 and day-5 onwards respectively. Thesurvival analysis consistently showed a decreased hazard for early onset ofpain in both the Turmacin groups. On day-84, the difference in mean ROM betweenTurmacin 0.5g and placebo was 4.79 degrees (p=0.008) and that for Turmacin 1gand placebo was 2.34 degrees (p=0.306). The difference in muscle force forisokinetic contractions of the quadriceps at angular velocities of 120 and 180was significant between Turmacin 0.5g and placebo (p=0.002 and p=0.005respectively) while that for Turmacin 1g & Turmacin 0.5g (p=0.206 andp=0.414 respectively) and Turmacin 1g & Placebo (p=0.046 and p=0.037) werenot significant. However, in the within group analysis participants in Turmacin1g group had better preserved muscle functions than Turmacin 0.5g group atangular velocities of 120 and 180 when compared with placebo.

Conclusion: Turmacin (0.5g and 1g) was efficacious when compared toplacebo in increasing the pain threshold and knee ROM in healthy participants withminor adverse events.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • All consenting adults aged between 18 and 65 years judged by Investigator to be in general good health on the basis of medical history 2.No knee joint discomfort/pain at rest; 3.Must achieve a knee joint discomfort/pain score of at least ≥ 40 mm on visual analogue scale (VAS) for pain after 10 minutes of brisk walk on the stepmill equipment.

排除标准

  • 1.Having trauma or surgery histories that have affected the knee.
  • 2.Having a disease that results in bad intestinal absorption 3.Women of child bearing age who do not wish to use approved birth control methods during study 4.Being pregnant or breastfeeding.
  • 5.Allergic or hypersensitive to turmeric 6.Being participating or having participated in a clinical assay or intervention study within the previous 30 days before inclusion in the study 7.Being unable to follow the guidelines of the study 8.Subjects having liver problems (raised ALT, AST), Heart (abnormal ECG / ECHO), kidney problems (raised creatinine), other muscle related problems (raised creatine kinase).
  • 9.Subjects having neurological disorders 10.BMI greater than 32 kg/m2
  • Taking concomitant medication like pain relievers or complements/ multivitamin supplements/ phytotherapeutical products that interfere with the product or outcomes of the study.
  • 12.Suffering from any kind of arthritic condition viz., autoimmune, infectious in the knee that could mislead the evaluation.

结局指标

主要结局

Joint pain reported on visual analogue scale

时间窗: days 5,7,28,56,84

次要结局

  • Maximal isometric torque will be measured with knee extension from the knee flexed (90 degree) position(Days 1 & 84)
  • isometric and isokinetic knee extension for quadriceps and hamstrings at various angular velocity (60 degree/sec to 300 degree/sec)(Days 1 & 84)
  • Isokinetic strength assessed in different velocities in random order(Days 1 & 84)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验